Stanley F. Handel
University of Texas MD Anderson Cancer Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stanley F. Handel.
Cancer | 1984
Lynn G. Feun; Sidney Wallace; David J. Stewart; Vincent P. Chuang; W. K. A. Yung; Milam E. Leavens; M. Andrew Burgess; Niramol Savaraj; Robert S. Benjamin; Sue Ellen Young; Rosa A. Tang; Stanley F. Handel; Giora M. Mavligit; William S. Fields
Thirty‐five patients with malignant brain tumors (23 with primary brain tumors and 12 with brain metastases) progressing after cranial irradiation chemotherapy received cisplatin, 60 to 120 mg/m2, into the internal carotid artery by a transfemoral approach. Courses of therapy were repeated every 4 weeks. Therapeutic evaluation was performed monthly using the CT scan of the brain and clinical neurologic examination. Thirty patients were evaluable for response. Of 20 evaluable patients with primary malignant brain tumors, 6 responded to therapy and 5 had stable disease. The median time to tumor progression for responding patients was 33 weeks, for stable patients 16 weeks, and 13 weeks for all patients. Five of 10 evaluable patients with brain metastases responded to intracarotid cisplatin, and 2 patients had stable disease. The estimated median time to progression for responding patients was 30+ weeks and 12+ weeks for patients with stable disease. Side effects included seizures in 5 courses, mental agitation and motor restlessness in 1, and transient hemiparesis in 7. One patient may have had a drug‐related death, and one patient appeared to develop encephalopathy after treatment. Five patients had clinical deterioration in vision; in two patients it was bilateral. Intracarotid cisplatin has definite activity in patients with malignant primary brain tumors and in patients with brain metastases. The recommended starting dose for intracarotid cisplatin is 60 to 75 mg/m2. At this dose level side effects are uncommon, but includes the risk of neurologic and retinal toxicity.
Radiology | 1979
Vincent P. Chuang; Sidney Wallace; David Swanson; Jesus Zornoza; Stanley F. Handel; Donald A. Schwarten; John G. Murray
Arterial embolization was performed in nine patients with metastases from renal carcinoma who had severe pain resistant to conventional therapy. Patients with metastases in the ilium (four), the lumbosacral spine (one), and the base of the skull (one) experienced pain relief lasting from one to six months. The other three patients, who had metastases in the proximal femur, underwent preoperative embolization to facilitate tumor curettage and internal hip fixation. No significant complications were seen with this therapeutic approach.
Radiology | 1979
Vijay K. Sadhu; Jerry Sampson; Floyd L. Haar; Richard S. Pinto; Stanley F. Handel
A preliminary retrospective correlation between computed tomographic scans and intracranial pressure (ICP) monitored was performed for 21 patients. No patient with a normal CT scan had elevated ICP. The lowest correlation was noted with slit ventricles; the highest, with dilatation of the contralateral temporal horn.
Radiology | 1979
Chandra S. Katragadda; Stewart R. Fogel; Gerald Cohen; Louis K. Wagner; Iii Charles Morgan; Stanley F. Handel; Shared R. Amtey; Richard G. Lester
A prototype computed radiography (CR) system was evaluated for its efficacy as an independent diagnostic modality. Preliminary measurements of high contrast resolution, low contrast perceptibility, and dose were obtained. Clinical examinations including skull, abdomen, liver, gallbladder, biliary system, spine, and extremities were performed as an adjunct to either computed tomography or CR. The data suggest that CR can be an effective diagnostic imaging modality by itself. Advantages over conventional radiography include high scatter rejection, low patient dose, wide dynamic range, and good low contrast sensitivity for large objects; disadvantages, its long exposure time and relatively poor high contrast spatial resolution.
Radiology | 1979
Julius Danziger; Sidney Wallace; Stanley F. Handel; Naguib B. Samaan
Pituitary hyperplasia, or adenoma, may result from end or target organ failure as seen in primary hypothyroidism and hypogonadism. Associated enlargement of the sella turcica and contour alterations without significant increase in volume may be seen. A review was made of 12 patients with end organ failure demonstrating the spectrum of radiologic changes within the sella turcica. Recognition of pituitary enlargement resulting from end organ failure may eliminate unnecessary surgery.
Spine | 1991
Stanley F. Handel; Thomas W. Twiford; Donald H. Reigel; Howard H. Kaufman
The radiographic findings in 4 patients with fractures of the lumbar vertebral ring apophysis are reported. All patients had a bony ridge or fragment projecting into the spinal canal, usually from the lower border of L4; a defect in the postero-inferior aspect of the vertebral body; and either an anterior extradural impression or complete blockage on the myelogram. Computed tomography was performed on one patient and appears to be helpful in demonstrating bone within the spinal canal. Preoperative diagnosis can facilitate selection of the appropriate surgical approach.
Neurology | 1991
Raymond A. Martin; Stanley F. Handel; Alfonso E. Aldama
A young man with headache was unable to sneeze despite a strong sensory urge to do so. Magnetic resonance imaging revealed a cystic neoplasm in the medulla oblongata that presumably interrupted the efferent arc of the sneezing reflex.
Cancer Research | 1982
David J. Stewart; Sidney Wallace; Lynn G. Feun; Milam E. Leavens; Sue Ellen Young; Stanley F. Handel; Giora M. Mavligit; Robert S. Benjamin
Journal of Computer Assisted Tomography | 1980
Howard H. Kaufman; Joel M. Singer; Vijay K. Sadhu; Stanley F. Handel; Gerald Cohen
Archives of Otolaryngology-head & Neck Surgery | 1977
Stanley F. Handel; Mark H. Miller; Lowell S. Miller; Helmuth Goepfert; Sidney Wallace